Bernd Leplow

Prof. Dr. Bernd Leplow


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
RSRobby Schoenfeld
Robby Schoenfeld
TSThomas Schiffelholz
Thomas Schiffelholz
CBChristian Beyer
Christian Beyer
BLBernd Leplow
Bernd Leplow
NFNigel Foreman
Nigel Foreman

1 August 2014 in Behavioural Brain Research
Verified
Journal Article
Closed access
RSR. Schoenfeld
R. Schoenfeld
NFN. Foreman
N. Foreman
BLBernd Leplow
Bernd Leplow

28 September 2009 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
JAJohannes Adler
Johannes Adler
YPYvonne Paelecke-Habermann
Yvonne Paelecke-Habermann
PJPatrick Jahn
Patrick Jahn
MLMargarete Landenberger
Margarete Landenberger
BLBernd Leplow
Bernd Leplow
DVDirk Vordermark
Dirk Vordermark
The availability of alternative sources of information, e. g. the internet, may influence the quantity and quality of information cancer patients receive regarding their disease and treatment. The purpose of the present study was to assess perception of information in cancer patients during radiotherapy as well as media preferences and specifically the utilization of the internet.

15 November 2016 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
BLBernd Leplow
Bernd Leplow
MSMaria Sepke
Maria Sepke
RSRobby Schönfeld
Robby Schönfeld
JPJohannes Pohl
Johannes Pohl
HOHenriette Oelsner
Henriette Oelsner
GEGeorg Ebersbach
Georg Ebersbach

1 September 2017 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
BLBernd Leplow
Bernd Leplow
AEAnna Eggebrecht
Anna Eggebrecht
JPJohannes Pohl
Johannes Pohl
Background: Differential effects of botulinum toxin (BoNT) treatment in cervical dystonia (CD) and blepharospasm (BSP) treatment satisfaction and emotional responses to a life with a disabling condition were investigated. Special interest was drawn to the course within a BoNT treatment cycle and the effects of subjective well-being vs perceived intensity of motor symptoms and quality of life. Methods: A questionnaire was distributed among 372 CD patients and 125 BSP patients, recruited from 13 BoNT centers throughout Germany. Items were related to dystonic symptoms, BoNT treatment responses and treatment satisfaction, quality of life, working situation, and emotional reactions to a life with dystonia. Results: CD patients and BSP patients were widely satisfied with BoNT treatment, but treatment satisfaction worsened significantly within the treatment cycle. Especially CD patients reported that both the dystonic symptoms and the effects of BoNT treatment were influenced by emotional factors. Despite good overall treatment effects, patients from both groups perceived marked persistence of motor symptoms, restrictions of everyday life functions, and reduced quality of life. Functional amelioration of motor symptoms and emotional well-being were only moderately correlated. About 22% of patients from both groups reported mental disorders or emotional disturbances prior to the onset of dystonia. Conclusion: As numerous psychological factors determine perceived outcome, BoNT treatment should be further improved by patient’s education strategies enhancing behavioral self-control. From the patient’s perspective, individual intervals, which may avoid exacerbation between injection points, should be considered. Moreover, patients at risk, with reduced adherence and poor BoNT outcome, should be identified and addressed within psychoeducation.

18 November 2012 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SGSimone Goebel
Simone Goebel
LALubomir Atanassov
Lubomir Atanassov
GKGünter Köhnken
Günter Köhnken
HMH. Maximilian Mehdorn
H. Maximilian Mehdorn
BLBernd Leplow
Bernd Leplow